Early detection of prostate cancer. Is serum PSA testing alone sufficient?

被引：0
|
作者：
Boergermann, C. [1 ,2 ]
vom Dorp, F. [2 ]
Breuer, G. [1 ]
Kliner, S. [1 ,2 ]
Ruebben, H. [2 ]
机构：
[1] Krankenhaus Duren gGmbH, Klin & Poliklin Urol Urol Onkol & Kinderurol, D-52351 Duren, Germany
[2] Univ Klin Essen, Klin & Poliklin Urol Uroonkol & Kinderurol, Essen, Germany
来源：
UROLOGE | 2010年 / 49卷 / 11期
关键词：
Prostate-specific antigen; Prostate cancer antigen 3; human; Screening; Prostate cancer; DIGITAL RECTAL EXAMINATION; MULTICENTER CLINICAL-TRIAL; SCREENING TRIAL; ANTIGEN DENSITY; MEN; VOLUME; DIFFERENTIATION; HYPERPLASIA; CARCINOMA; DIAGNOSIS;
D O I：
10.1007/s00120-010-2394-5
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The euphoria over PSA as an optimal marker for prostate cancer is gone. Measuring PSA levels has several deficiencies in detecting prostate cancer. First results of the randomized studies ERSPC and PLCO were not able to conclusively prove the value of PSA-based screening. Many attempts have been made to optimize early detection of prostate cancer like using modern imaging techniques or new biomarkers. This review deals with PSA isoforms und emerging biomarkers for the diagnosis of prostate cancer. Despite the inadequacies of PSA it is still the most important marker for the early detection of prostate cancer. Modern biomarkers with the ability to reliably predict aggressive prostate cancer are still missing.
引用
收藏
页码：1351 / +
页数：4
相关论文
共 50 条
  • [1] Malpractice implications of PSA testing for early detection of prostate cancer.
    Collins, MFM
    Barry, MJ
    Roberts, RG
    Fowler, FJ
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (07) : A406 - A406
  • [2] Früherkennung von ProstatakarzinomenIst die Untersuchung des Serum-PSA alleine ausreichend?Early detection of prostate cancerIs serum PSA testing alone sufficient?
    C. Börgermann
    F. vom Dorp
    G. Breuer
    S. Kliner
    H. Rübben
    [J]. Der Urologe, 2010, 49 (11): : 1351 - 1355
  • [3] Medical malpractice implications of PSA testing for early detection of prostate cancer
    Collins, MM
    Fowler, FJ
    Roberts, RG
    Oesterling, JE
    Annas, GJ
    Barry, MJ
    [J]. JOURNAL OF LAW MEDICINE & ETHICS, 1997, 25 (04): : 234 - +
  • [4] Debate Continues on Use of PSA Testing for Early Detection of Prostate Cancer
    Friedrich, M. J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (22): : 2273 - 2276
  • [5] PSA testing in detection and treatment of prostate cancer
    Lamb, David S.
    Delahunt, Brett
    Nacey, John N.
    [J]. NEW ZEALAND MEDICAL JOURNAL, 2011, 124 (1345) : 13 - 15
  • [6] Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
    Hoti, Naseruddin
    Lih, Tung-Shing
    Dong, Mingming
    Zhang, Zhen
    Mangold, Leslie
    Partin, Alan W.
    Sokoll, Lori J.
    Kay Li, Qing
    Zhang, Hui
    [J]. CANCERS, 2023, 15 (03)
  • [7] Community-based estimates of the operating characteristics of serum prostate-specific antigen (PSA) determinations in the early detection of prostate cancer.
    Jacobsen, SJ
    Bergstralh, EJ
    Guess, HA
    Klee, GG
    Oesterling, JE
    Katusic, SK
    Lieber, MM
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1996, 143 (11) : 308 - 308
  • [8] Complexed PSA enhances specificity in the detection of prostate cancer.
    Cheli, CD
    Miller, MC
    Veltri, R
    [J]. CLINICAL CHEMISTRY, 2001, 47 (06) : A128 - A128
  • [9] FREQUENCY OF PSA TESTING IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER.
    Bokhorst, Leonard
    Alberts, Arnout
    Kakehi, Yoshiyuki
    Rannikko, Antti
    Pickles, Tom
    Valdagni, Riccardo
    Bangma, Chris
    Roobol, Monique
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E755 - E755
  • [10] The use of a third generation chemiluminescent PSA assay for the early detection of recurrent prostate cancer.
    Vallorosi, CJ
    Giacherio, DA
    Beduschi, MC
    England, BG
    Montie, JE
    Wojno, KJ
    [J]. CLINICAL CHEMISTRY, 1998, 44 : A38 - A38
12345